Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{186058,
        author = {Syed Yunis Bukhari and MD Azad Alam and Aditya Kamboj and Ameen Heshmat Ali and Abrar Hussain Joo and Syed Tufail and Ritika Dadwal and Amandeep Kaur},
        title = {Antimicrobial Resistance and Tuberculosis: Emerging Threats and Strategies for Global Control},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {6},
        pages = {489-492},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=186058},
        abstract = {Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains one of the leading infectious killers globally. The emergence of antimicrobial resistance (AMR), particularly multi-drug resistant (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB), threatens decades of progress in TB control. Resistance arises primarily due to incomplete treatment, improper prescription, and spontaneous genetic mutations. This review summarizes current knowledge on AMR in tuberculosis, mechanisms of resistance, diagnostic challenges, treatment strategies, and the role of surveillance and stewardship programs. Integrating AMR control into global TB strategies is essential to prevent the spread of resistant strains and safeguard public health.},
        keywords = {Tuberculosis, Antimicrobial Resistance (AMR), MDR-TB, XDR-TB, Drug resistance, public health, WHO, Mycobacterium tuberculosis, Diagnosis, Treatment failure, Global health},
        month = {December},
        }